ZNTL · Company research
Zentalis Pharmaceuticals, Inc. (ZNTL): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 2.67 | $193,650,090 | 168867090.000 | — | — | — | — | 1.34810638653356167244 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.